Search by Drug Name or NDC

NDC 68974-0200-30 FILSPARI 200 mg/1 Details

FILSPARI 200 mg/1

FILSPARI is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Travere Therapeutics, Inc.. The primary component is SPARSENTAN.

MedlinePlus Drug Summary

Sparsentan is used reduce proteinuria (increased protein in urine) in certain patients with primary immunoglobulin A (IgA) nephropathy (a kidney disease where IgA deposits build up in the kidneys causing inflammation). Sparsentan is in a class of medications called endothelin and angiotensin II receptor antagonists. It works by blocking two substances, endothelin and angiotensin II, that play a role in the progression of kidney disease.

Related Packages: 68974-0200-30
Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Sparsentan

Product Information

NDC	68974-0200
Product ID	68974-200_6ed15d2c-3348-4c27-9853-414cb9e4bb94
Associated GPIs
GCN Sequence Number	084437
GCN Sequence Number Description	sparsentan TABLET 200 MG ORAL
HIC3	A4Q
HIC3 Description	ENDOTHELIN-ANGIOTENSIN RECEPTOR ANTAGONIST
GCN	53742
HICL Sequence Number	048721
HICL Sequence Number Description	SPARSENTAN
Brand/Generic	Brand
Proprietary Name	FILSPARI
Proprietary Name Suffix	n/a
Non-Proprietary Name	sparsentan
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	SPARSENTAN
Labeler Name	Travere Therapeutics, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA216403
Listing Certified Through	2024-12-31

Package

NDC 68974-0200-30 (68974020030)

Pricing Information	N/A
NDC Package Code	68974-200-30
Billing NDC	68974020030
Package	30 TABLET, FILM COATED in 1 BOTTLE (68974-200-30)
Marketing Start Date	2023-02-17
NDC Exclude Flag	N